Interestingly, CRISPR-based genome editing techniques were found to detect changes in ABCC8 and SUR1 expression levels in type 2 diabetes, suggesting that gene editing could be useful in diagnosing and treating KATP channel mutations in the future (Zhou et al., 2019b). Here, ABCC8 is linked to type 2 diabetes mellitus.